DR. RICHARD PIEKARZ, MD
Osteopathic Medicine in Bethesda, MD
License number
Maryland D51303
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
2
10 Center Dr, Bethesda, MD 20892
1424 Crestridge Dr, Silver Spring, MD 20910
1424 Crestridge Dr, Silver Spring, MD 20910
Phone
(301) 402-3524
(301) 402-1608 (Fax)
(301) 587-4252
(301) 402-1608 (Fax)
(301) 587-4252
Personal information
See more information about RICHARD PIEKARZ at radaris.comName
Address
Phone
8708 1St Ave APT 309, Silver Spring, MD 20910
Silver Spring, MD
8708 1St Ave, Silver Spring, MD 20910
1424 Crestridge Dr, Silver Spring, MD 20910
1813 Snowdrop Ln, Silver Spring, MD 20906
Organization information
See more information about RICHARD PIEKARZ at bizstanding.comRichard Piekarz MD,PHD
1424 Crestridge Dr, Silver Spring, MD 20910
Industry:
Internist
Richard Lawrence Piekarz
Professional information
See more information about RICHARD PIEKARZ at trustoria.com
Dr. Richard Piekarz, Bethesda MD - MD (Doctor of Medicine)
Dr. Richard Piekarz, Bethesda MD - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
VALID FOR US CIVIL SERVICE EMPLOYEE ON
10 Ctr Dr, Bethesda 20892
(301) 496-0207 (Phone)
10 Ctr Dr, Bethesda 20892
(301) 402-3524 (Phone), (301) 402-1608 (Fax)
10 Ctr Dr, Bethesda 20892
(301) 496-0207 (Phone)
10 Ctr Dr, Bethesda 20892
(301) 402-3524 (Phone), (301) 402-1608 (Fax)
Certifications:
Internal Medicine, 1997, Medical Oncology, 2001
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Albert Einstein College of Medicine of Yeshiva University
Graduated: 1993
U Hosps Of Cleveland
Nih-Nat Cancer Inst
Albert Einstein College of Medicine of Yeshiva University
Graduated: 1993
U Hosps Of Cleveland
Nih-Nat Cancer Inst
Richard Lawrence Piekarz, Bethesda MD
Richard Lawrence Piekarz, Bethesda MD
Specialties:
Internal Medicine, Medical Oncology, Public Health & General Preventive Medicine
Work:
National Institutes Of Health
10 Ctr Dr, Bethesda, MD 20892
10 Ctr Dr, Bethesda, MD 20892
Education:
Yeshiva University (1994)
Richard Lawrence Piekarz, Bethesda MD
Richard Lawrence Piekarz, Bethesda MD
Specialties:
Oncologist
Address:
10 Center Dr, Bethesda, MD 20892
Education:
Yeshiva University, Albert Einstein College of Medicine - Doctor of Medicine
Deacetylase Inhibitor Therapy
Deacetylase Inhibitor Therapy
US Patent:
2008012, May 29, 2008
Filed:
Jun 7, 2007
Appl. No.:
11/759471
Inventors:
William McCulloch - Raleigh NC, US
Richard L. Piekarz - Silver Spring MD, US
Susan E. Bates - Bethesda MD, US
Richard L. Piekarz - Silver Spring MD, US
Susan E. Bates - Bethesda MD, US
International Classification:
A61K 33/06, A61K 33/24, A61P 25/00, A61P 35/00, A61P 35/02, A61P 37/00
US Classification:
424682, 424617
Abstract:
The present invention relates to deacetylase inhibitor (e.g., histone deacetylase inhibitor) therapies and demonstrates that individuals with low electrolyte levels may have increased susceptibility to certain unwanted side effects such as cardiac side effects. In some embodiments, the invention provides methods of administering DAC or DAC inhibitor therapy that includes electrolyte supplementation.
Topical Formulations Of Histone Deacetylase Inhibitors And Methods Using The Same
Topical Formulations Of Histone Deacetylase Inhibitors And Methods Using The Same
US Patent:
2008029, Nov 27, 2008
Filed:
Aug 15, 2006
Appl. No.:
12/064220
Inventors:
Susan E. Bates - Bethesda MD, US
Antonio Tito Fojo - Rockville MD, US
Richard L. Piekarz - Silver Spring MD, US
John J. Wright - Falls Church VA, US
George J. Grimes - Rockville MD, US
Karen M. Schweikart - Centreville VA, US
Antonio Tito Fojo - Rockville MD, US
Richard L. Piekarz - Silver Spring MD, US
John J. Wright - Falls Church VA, US
George J. Grimes - Rockville MD, US
Karen M. Schweikart - Centreville VA, US
Assignee:
Government of the United of America, Represented by the Secretary, Department of Health and.... - Rockville MD
International Classification:
A61K 38/02, A61K 39/395, A61K 38/07, A61K 31/165, A61P 35/00
US Classification:
4241301, 514 2, 514 18, 514646
Abstract:
Disclosed are topical compositions comprising at least one histone deacetylase (HDAC) inhibitor (HDI) and a carrier comprising petrolatum. Methods for using such compositions to treat or inhibit cancer and various skin diseases are also disclosed.
Materials And Methods For Abcb1 Polymorphic Variant Screening, Diagnosis, And Treatment
Materials And Methods For Abcb1 Polymorphic Variant Screening, Diagnosis, And Treatment
US Patent:
2009032, Dec 31, 2009
Filed:
Nov 9, 2006
Appl. No.:
12/093225
Inventors:
William D. Figg - Fairfax VA, US
Alexander Sparreboom - Memphis TN, US
Tristan Sissung - Annandale VA, US
Richard L. Piekarz - Silver Spring MD, US
Susan E. Bates - Bethesda MD, US
Alexander Sparreboom - Memphis TN, US
Tristan Sissung - Annandale VA, US
Richard L. Piekarz - Silver Spring MD, US
Susan E. Bates - Bethesda MD, US
Assignee:
Government of the United States of America, as Represented by Secretary, Dept. of Human Services - Rockville MD
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The invention provides methods and materials for screening for polymorphic variants in ABCB1 and diagnosing altered susceptibilities for drug-induced heart rhythm irregularities based on the same. These methods allow better treatment regimens for using drugs that bind a protein encoded by the ABCB1 and/or induce heart rhythm irregularities such as the anti-cancer drug FK228.